Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Ardagh Group price target raised to $20 from $17 at Deutsche Bank » 07:20
10/26/20
10/26
07:20
10/26/20
07:20
ARD

Ardagh Group

$16.53 /

+0.23 (+1.41%)

Deutsche Bank analyst…

Deutsche Bank analyst Debbie Jones raised the firm's price target on Ardagh Group to $20 from $17 and keeps a Buy rating on the shares following the company's "strong" Q3 results.The analyst sees "impressive growth with significant capital investment ahead."

ShowHide Related Items >><<
ARD Ardagh Group
$16.53 /

+0.23 (+1.41%)

10/26/20 Citi
Ardagh Group price target raised to $21 from $17 at Citi
10/16/20 Credit Suisse
Ardagh assumed with an Outperform from Neutral at Credit Suisse
07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
ARD Ardagh Group
$16.53 /

+0.23 (+1.41%)

ARD Ardagh Group
$16.53 /

+0.23 (+1.41%)

Recommendations
Ardagh Group price target raised to $21 from $17 at Citi » 06:26
10/26/20
10/26
06:26
10/26/20
06:26
ARD

Ardagh Group

$16.53 /

+0.23 (+1.41%)

Citi analyst Anthony…

Citi analyst Anthony Pettinari raised the firm's price target on Ardagh Group to $21 from $17 and keeps a Buy rating on the shares. The company posted a Q3 beat but "more importantly" detailed a $1.8B investment program that will add 16B beverage can capacity through 2024, Pettinari tells investors in a research note. The analyst remains positive on the can makers.

ShowHide Related Items >><<
ARD Ardagh Group
$16.53 /

+0.23 (+1.41%)

10/16/20 Credit Suisse
Ardagh assumed with an Outperform from Neutral at Credit Suisse
07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
ARD Ardagh Group
$16.53 /

+0.23 (+1.41%)

ARD Ardagh Group
$16.53 /

+0.23 (+1.41%)

Over a week ago
Earnings
Ardagh Group reports Q3 adjusted EPS 48c, consensus 40c » 07:03
10/22/20
10/22
07:03
10/22/20
07:03
ARD

Ardagh Group

$14.80 /

+0.11 (+0.75%)

Reports Q3 revenue…

Reports Q3 revenue $1.80B, consensus $1.73B. CEO Paul Coulson said, "The Group performed very well in the quarter in a challenging operating environment, with continued strong growth in Metal Beverage Packaging and resumed volume growth in Glass Packaging, as on-premise channels re-opened. Our 2020 $250M Business Growth Investment program has progressed well and will deliver new beverage can capacity in North America later this quarter. In addition, given a very favorable long-term outlook for sustainable packaging, we plan to invest over $1.8B in organic growth projects in 2021 to 2024, in addition to maintenance capex. This investment, will be principally in our beverage can business."

ShowHide Related Items >><<
ARD Ardagh Group
$14.80 /

+0.11 (+0.75%)

10/16/20 Credit Suisse
Ardagh assumed with an Outperform from Neutral at Credit Suisse
07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
ARD Ardagh Group
$14.80 /

+0.11 (+0.75%)

ARD Ardagh Group
$14.80 /

+0.11 (+0.75%)

Upgrade
Ardagh assumed with an Outperform from Neutral at Credit Suisse » 15:07
10/16/20
10/16
15:07
10/16/20
15:07
ARD

Ardagh Group

$14.13 /

+0.29 (+2.10%)

Credit Suisse analyst…

Credit Suisse analyst Curt Woodworth upgraded Ardagh Group to Outperform from Neutral with a price target of $20, up from $17.20, after assuming coverage of the name. The analyst assumed coverage of the U.S. beverage can packaging sector with a "bullish" medium-term outlook. Ardagh is a leading producer of beverage cans and glass containers, with "top 3" share and "best-in-class" specialty mix across its major markets, Woodworth tells investors in a research note. The analyst sees the company adding at least 3B units of new can capacity in the Americas over the next 12-24 months, with "strong leverage in key verticals" across hard seltzer and craft beer. He believes the Street is underestimating Ardagh's beverage growth.

ShowHide Related Items >><<
ARD Ardagh Group
$14.13 /

+0.29 (+2.10%)

07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
ARD Ardagh Group
$14.13 /

+0.29 (+2.10%)

ARD Ardagh Group
$14.13 /

+0.29 (+2.10%)

Over a quarter ago
Earnings
Ardagh Group reports Q2 adjusted EPS ,37c consensus 30c » 07:02
07/23/20
07/23
07:02
07/23/20
07:02
ARD

Ardagh Group

$14.00 /

+0.28 (+2.04%)

Reports Q2 revenue…

Reports Q2 revenue $1.61B, consensus $1.61B. Paul Coulson, Chairman and Chief Executive, said, "The Group performed well in the quarter, reflecting strong execution and the defensive end markets we serve. Earnings grew in Metal Beverage Packaging, while Glass Packaging's performance was very resilient. Demand for sustainable packaging remains strong and we continue to progress our growth investment projects. We also availed of favourable markets to improve our capital structure and ended the quarter with total liquidity of $1.6B. Overall trading trends in June were positive and we are well-positioned to benefit from further improvements in market demand."

ShowHide Related Items >><<
ARD Ardagh Group
$14.00 /

+0.28 (+2.04%)

07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
ARD Ardagh Group
$14.00 /

+0.28 (+2.04%)

ARD Ardagh Group
$14.00 /

+0.28 (+2.04%)

On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:36
07/15/20
07/15
16:36
07/15/20
16:36
BLL

Ball Corp.

$69.47 /

-4.16 (-5.65%)

, CCK

Crown Holdings

$67.10 /

-1.655 (-2.41%)

, GS

Goldman Sachs

$216.83 /

+2.54 (+1.19%)

, JPM

JPMorgan

$99.74 /

+1.52 (+1.55%)

, UNH

UnitedHealth

$304.14 /

-4.44 (-1.44%)

, MRNA

Moderna

$80.23 /

+5.19 (+6.92%)

, AZN

AstraZeneca

$57.98 /

+4.01 (+7.43%)

, WMT

Walmart

$131.99 /

-0.04 (-0.03%)

, FSCT

ForeScout

$28.89 /

+3.92 (+15.70%)

, ORGO

Organogenesis

$3.88 /

+0.63 (+19.38%)

, ARD

Ardagh Group

$13.47 /

+0.2 (+1.51%)

, BK

BNY Mellon

$36.85 /

-2.14 (-5.49%)

Stocks were rallying in…

ShowHide Related Items >><<
WMT Walmart
$131.99 /

-0.04 (-0.03%)

UNH UnitedHealth
$304.14 /

-4.44 (-1.44%)

ORGO Organogenesis
$3.88 /

+0.63 (+19.38%)

MRNA Moderna
$80.23 /

+5.19 (+6.92%)

JPM JPMorgan
$99.74 /

+1.52 (+1.55%)

GS Goldman Sachs
$216.83 /

+2.54 (+1.19%)

FSCT ForeScout
$28.89 /

+3.92 (+15.70%)

CCK Crown Holdings
$67.10 /

-1.655 (-2.41%)

BLL Ball Corp.
$69.47 /

-4.16 (-5.65%)

BK BNY Mellon
$36.85 /

-2.14 (-5.49%)

AZN AstraZeneca
$57.98 /

+4.01 (+7.43%)

BLL Ball Corp.
$69.47 /

-4.16 (-5.65%)

07/15/20 Jefferies
Canpack's new Scranton plant 'modest negative' for Ball, Crown, says Jefferies
07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
07/13/20 Jefferies
Ball Corp. assumed with a Hold at Jefferies
06/01/20 Atlantic Equities
Ball Corp. initiated with a Neutral at Atlantic Equities
CCK Crown Holdings
$67.10 /

-1.655 (-2.41%)

07/13/20 Jefferies
Crown Holdings assumed with a Buy at Jefferies
GS Goldman Sachs
$216.83 /

+2.54 (+1.19%)

07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
07/16/20 Oppenheimer
Goldman Sachs price target raised to $355 from $335 at Oppenheimer
07/16/20 RBC Capital
Goldman Sachs price target raised to $225 from $200 at RBC Capital
07/16/20 Credit Suisse
Goldman Sachs price target raised to $255 from $240 at Credit Suisse
JPM JPMorgan
$99.74 /

+1.52 (+1.55%)

07/15/20 BMO Capital
JPMorgan price target raised to $119 from $108 at BMO Capital
07/09/20 Wolfe Research
JPMorgan upgraded to Outperform from Peer Perform at Wolfe Research
07/09/20 DA Davidson
JPMorgan upgraded to Buy from Neutral at DA Davidson
07/08/20 Seaport Global
JPMorgan initiated with a Buy at Seaport Global
UNH UnitedHealth
$304.14 /

-4.44 (-1.44%)

07/16/20 SVB Leerink
UnitedHealth price target raised to $370 from $360 at SVB Leerink
07/16/20 Oppenheimer
UnitedHealth price target raised to $353 from $343 at Oppenheimer
07/16/20 Deutsche Bank
UnitedHealth price target raised to $312 from $293 at Deutsche Bank
07/16/20 Credit Suisse
UnitedHealth price target raised to $335 from $325 at Credit Suisse
MRNA Moderna
$80.23 /

+5.19 (+6.92%)

07/16/20 B. Riley Securities
Novavax price target raised to $155 from $106 at B. Riley FBR
07/15/20 JPMorgan
JPMorgan 'encouraged' by results of Moderna COVID vaccine candidate
07/15/20 Piper Sandler
Moderna price target raised to $134 from $100 at Piper Sandler
07/15/20 Goldman Sachs
Moderna Phase 1 COVID-19 vaccine data 'impresses,' says Goldman Sachs
AZN AstraZeneca
$57.98 /

+4.01 (+7.43%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
WMT Walmart
$131.99 /

-0.04 (-0.03%)

07/14/20 Oppenheimer
Walmart+ could better defend against Amazon grocery threat, says Oppenheimer
07/12/20 Jefferies
Walmart/Target e-comm growth not seen coming at Amazon's expense, says Jefferies
07/10/20 Morgan Stanley
Walmart 'a sleeping giant to watch' in healthcare, says Morgan Stanley
07/09/20 Craig-Hallum
Craig-Hallum remains bullish on eHealth as Walmart helps validate opportunity
FSCT ForeScout
$28.89 /

+3.92 (+15.70%)

05/29/20 UBS
ForeScout price target lowered to $25 from $36 at UBS
02/18/20 Baird
ForeScout acquired, Baird downgrades to Neutral
02/18/20 Baird
ForeScout downgraded to Neutral from Outperform at Baird
02/07/20 Berenberg
ForeScout downgraded to Hold from Buy at Berenberg
ORGO Organogenesis
$3.88 /

+0.63 (+19.38%)

03/06/20 Credit Suisse
Organogenesis price target lowered to $8 from $10 at Credit Suisse
01/10/20 SVB Leerink
Organogenesis initiated with an Outperform at SVB Leerink
08/26/19 Credit Suisse
Organogenesis reinstated with an Outperform at Credit Suisse
ARD Ardagh Group
$13.47 /

+0.2 (+1.51%)

04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
BK BNY Mellon
$36.85 /

-2.14 (-5.49%)

07/08/20 Seaport Global
BNY Mellon initiated with a Buy at Seaport Global
07/08/20 Jefferies
BNY Mellon upgraded to Buy on positive EPS revisions at Jefferies
07/08/20 Jefferies
BNY Mellon upgraded to Buy from Hold at Jefferies
06/11/20 Deutsche Bank
BNY Mellon named short-term investment idea at Deutsche Bank
WMT Walmart
$131.99 /

-0.04 (-0.03%)

UNH UnitedHealth
$304.14 /

-4.44 (-1.44%)

ORGO Organogenesis
$3.88 /

+0.63 (+19.38%)

MRNA Moderna
$80.23 /

+5.19 (+6.92%)

JPM JPMorgan
$99.74 /

+1.52 (+1.55%)

GS Goldman Sachs
$216.83 /

+2.54 (+1.19%)

FSCT ForeScout
$28.89 /

+3.92 (+15.70%)

CCK Crown Holdings
$67.10 /

-1.655 (-2.41%)

BLL Ball Corp.
$69.47 /

-4.16 (-5.65%)

BK BNY Mellon
$36.85 /

-2.14 (-5.49%)

AZN AstraZeneca
$57.98 /

+4.01 (+7.43%)

ARD Ardagh Group
$13.47 /

+0.2 (+1.51%)

  • 19
    May
  • 12
    Feb
  • 22
    Nov
WMT Walmart
$131.99 /

-0.04 (-0.03%)

UNH UnitedHealth
$304.14 /

-4.44 (-1.44%)

MRNA Moderna
$80.23 /

+5.19 (+6.92%)

JPM JPMorgan
$99.74 /

+1.52 (+1.55%)

GS Goldman Sachs
$216.83 /

+2.54 (+1.19%)

FSCT ForeScout
$28.89 /

+3.92 (+15.70%)

BLL Ball Corp.
$69.47 /

-4.16 (-5.65%)

BK BNY Mellon
$36.85 /

-2.14 (-5.49%)

AZN AstraZeneca
$57.98 /

+4.01 (+7.43%)

WMT Walmart
$131.99 /

-0.04 (-0.03%)

UNH UnitedHealth
$304.14 /

-4.44 (-1.44%)

MRNA Moderna
$80.23 /

+5.19 (+6.92%)

JPM JPMorgan
$99.74 /

+1.52 (+1.55%)

GS Goldman Sachs
$216.83 /

+2.54 (+1.19%)

FSCT ForeScout
$28.89 /

+3.92 (+15.70%)

CCK Crown Holdings
$67.10 /

-1.655 (-2.41%)

BLL Ball Corp.
$69.47 /

-4.16 (-5.65%)

BK BNY Mellon
$36.85 /

-2.14 (-5.49%)

AZN AstraZeneca
$57.98 /

+4.01 (+7.43%)

WMT Walmart
$131.99 /

-0.04 (-0.03%)

UNH UnitedHealth
$304.14 /

-4.44 (-1.44%)

MRNA Moderna
$80.23 /

+5.19 (+6.92%)

JPM JPMorgan
$99.74 /

+1.52 (+1.55%)

GS Goldman Sachs
$216.83 /

+2.54 (+1.19%)

FSCT ForeScout
$28.89 /

+3.92 (+15.70%)

BLL Ball Corp.
$69.47 /

-4.16 (-5.65%)

BK BNY Mellon
$36.85 /

-2.14 (-5.49%)

AZN AstraZeneca
$57.98 /

+4.01 (+7.43%)

Recommendations
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi » 15:08
07/15/20
07/15
15:08
07/15/20
15:08
CCK

Crown Holdings

$70.17 /

+1.415 (+2.06%)

, BLL

Ball Corp.

$74.22 /

+0.59 (+0.80%)

, ARD

Ardagh Group

$13.63 /

+0.36 (+2.71%)

After a local news outlet…

After a local news outlet in Pennsylvania reported that Can-Pack, the fourth-largest global beverage can producer, will build its first U.S. plant, said to be a state-of-the-art aluminum can facility, Citi analyst Anthony Pettinari said that he views the news as "a clear negative" for Ball Corp. (BLL), Crown Holdings (CCK) and Ardagh Group (ARD) if the report is accurate. Can-Pack has a history of impacting local can markets and he expects all three stocks to trade lower on the news, similar to when Florida Caribbean Distillers' greenfield beverage can facility was first announced, the analyst added.

ShowHide Related Items >><<
CCK Crown Holdings
$70.17 /

+1.415 (+2.06%)

BLL Ball Corp.
$74.22 /

+0.59 (+0.80%)

CCK Crown Holdings
$70.17 /

+1.415 (+2.06%)

07/13/20 Jefferies
Ball Corp. assumed with a Hold at Jefferies
07/13/20 Jefferies
Crown Holdings assumed with a Buy at Jefferies
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
03/23/20 Goldman Sachs
Ball Corp, Crown Holdings upgraded to Buy at Goldman Sachs
BLL Ball Corp.
$74.22 /

+0.59 (+0.80%)

06/01/20 Atlantic Equities
Ball Corp. initiated with a Neutral at Atlantic Equities
05/08/20 Barclays
Ball Corp. price target lowered to $72 from $82 at Barclays
ARD Ardagh Group
$13.63 /

+0.36 (+2.71%)

04/24/20 Barclays
Ardagh Group price target lowered to $15 from $22 at Barclays
04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
12/06/19 Citi
FCD can plant news potential negative for Ball, Crown and Ardagh, says Citi
CCK Crown Holdings
$70.17 /

+1.415 (+2.06%)

BLL Ball Corp.
$74.22 /

+0.59 (+0.80%)

ARD Ardagh Group
$13.63 /

+0.36 (+2.71%)

CCK Crown Holdings
$70.17 /

+1.415 (+2.06%)

CCK Crown Holdings
$70.17 /

+1.415 (+2.06%)

BLL Ball Corp.
$74.22 /

+0.59 (+0.80%)

BLL Ball Corp.
$74.22 /

+0.59 (+0.80%)

Recommendations
Ardagh Group price target lowered to $15 from $22 at Barclays » 06:50
04/24/20
04/24
06:50
04/24/20
06:50
ARD

Ardagh Group

$12.48 /

-0.215 (-1.69%)

Barclays analyst Michael…

Barclays analyst Michael Leithead lowered the firm's price target on Ardagh Group to $15 from $22 and keeps an Equal Weight rating on the shares following the company's Q1 results. The analyst believes Ardagh has sufficient liquidity and cash flow to manage through this period.

ShowHide Related Items >><<
ARD Ardagh Group
$12.48 /

-0.215 (-1.69%)

04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
12/06/19 Citi
FCD can plant news potential negative for Ball, Crown and Ardagh, says Citi
07/17/19 JPMorgan
Ardagh Group downgraded to Underweight from Neutral at JPMorgan
Earnings
Ardagh Group reports Q1 adjusted EPS 31c, consensus 28c » 07:03
04/23/20
04/23
07:03
04/23/20
07:03
ARD

Ardagh Group

$12.70 /

-0.065 (-0.51%)

Reports Q1 revenue…

Reports Q1 revenue $1.62B, consensus $1.62B. CEO Paul Coulson said "Q1 results were in line with our expectations, with no material impact from COVID-19. The commitment and dedication of our teams during this challenging period has been outstanding, enabling all our production facilities to continue to serve the beverage and food supply chain. It is too early to assess the macroeconomic impact of the pandemic and, accordingly, we are withdrawing our 2020 financial guidance. However, our defensive end markets, proven operating model and $1.5B in liquidity position us to successfully manage this uncertain environment."

ShowHide Related Items >><<
ARD Ardagh Group
$12.70 /

-0.065 (-0.51%)

04/17/20 Wells Fargo
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo
01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
12/06/19 Citi
FCD can plant news potential negative for Ball, Crown and Ardagh, says Citi
07/17/19 JPMorgan
Ardagh Group downgraded to Underweight from Neutral at JPMorgan
Downgrade
Ardagh Group downgraded to Underweight from Equal Weight at Wells Fargo » 06:18
04/17/20
04/17
06:18
04/17/20
06:18
ARD

Ardagh Group

$13.19 /

+0.35 (+2.73%)

Wells Fargo analyst Gabe…

Wells Fargo analyst Gabe Hajde downgraded Ardagh Group to Underweight from Equal Weight with a price target of $13, down from $21, in light of the ongoing COVID-19 outbreak to reflect a similar drop off in semi-discretionary end markets and premium products to the Great Recession. In a research note to investors, Hadje says this reflects low-to-mid teen declines in fragrance/cosmetic end markets as well as industrial applications, a meaningful contraction in away-from-home dining, and an increase in packaging necessary for at-home consumption.

ShowHide Related Items >><<
ARD Ardagh Group
$13.19 /

+0.35 (+2.73%)

01/16/20 Barclays
Ardagh Group initiated with an Equal Weight at Barclays
12/06/19 Citi
FCD can plant news potential negative for Ball, Crown and Ardagh, says Citi
07/17/19 JPMorgan
Ardagh Group downgraded to Underweight from Neutral at JPMorgan
06/19/19 Deutsche Bank
Constellium a winner of upcoming can sheet shortage, says Deutsche Bank

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.